{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:55:52Z","timestamp":1782924952955,"version":"3.54.5"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adenosine deaminase (ADA) deficiency is a rare genetic condition leading to severe combined immunodeficiency. Timely and accurate quantification of ADA activity is crucial for both diagnosis and treatment monitoring. This study describes the development and analytical validation of a high-performance liquid chromatography (HPLC)-based method for measuring ADA activity in dried blood spot (DBS) samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>ADA activity was quantified by measuring the enzymatic conversion of adenosine to inosine and hypoxanthine, followed by chromatographic separation and detection. Method validation was conducted according to current bioanalytical guidelines and included assessment of selectivity, linearity, sensitivity, precision, trueness, extraction recovery, and stability. The study involved 3 groups of samples taken from healthy pediatric donors (n = 116), carriers of pathogenic mutations (n = 13), and patients with genetically confirmed ADA deficiency (n = 11).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The assay demonstrated high selectivity and linearity over the tested concentration ranges (coefficient of determination &amp;gt; 0.99 for both analytes). The lower limit of quantification was 0.312 \u03bcg\/mL (2.29 \u03bcmol\/L) for hypoxanthine and 0.5 \u03bcg\/mL (1.86 \u03bcmol\/L) for inosine. A reference interval for ADA activity in DBS was established at 14.94 to 43.28 nmol\/h\/mg. The mean ADA activity was 25.06 nmol\/h\/mg of protein in the control group, 14.08 nmol\/h\/mg in mutation carriers, and 2.18 nmol\/h\/mg in patients with ADA deficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The developed method allows precise and reliable determination of ADA activity in DBS. It can be applied for the diagnosis and monitoring of patients with ADA deficiency, as well as in scientific studies related to purine metabolism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jalm\/jfag037","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:34:50Z","timestamp":1773329690000},"page":"758-769","source":"Crossref","is-referenced-by-count":0,"title":["Development, Validation, and Clinical Application of an HPLC-Based Method for Determining Adenosine Deaminase Activity in Adenosine Deaminase Deficiency-Severe Combined Immunodeficiency"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1451-7249","authenticated-orcid":false,"given":"Maria","family":"Petrik","sequence":"first","affiliation":[{"name":"Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology , Moscow ,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Litvin","sequence":"additional","affiliation":[{"name":"Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology , Moscow ,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Osipyants","sequence":"additional","affiliation":[{"name":"Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology , Moscow ,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Filkova","sequence":"additional","affiliation":[{"name":"Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology , Moscow ,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Rodina","sequence":"additional","affiliation":[{"name":"Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology , Moscow ,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitrii","family":"Blinov","sequence":"additional","affiliation":[{"name":"Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology , Moscow ,","place":["Russia"]},{"name":"Sechenov University, Moscow ,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay","family":"Grachev","sequence":"additional","affiliation":[{"name":"Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology , Moscow ,","place":["Russia"]},{"name":"Sechenov University, Moscow ,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Shcherbina","sequence":"additional","affiliation":[{"name":"Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology , Moscow ,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"2026070109541865900_jfag037-B1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13023-018-0807-5","article-title":"Adenosine deaminase deficiency: a review","volume":"13","author":"Flinn","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"2026070109541865900_jfag037-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(04)86001-2","article-title":"Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation","volume":"86","author":"Blackburn","year":"2005","journal-title":"Adv Immunol"},{"key":"2026070109541865900_jfag037-B3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fimmu.2012.00265","article-title":"Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency","volume":"3","author":"Sauer","year":"2012","journal-title":"Front Immunol"},{"key":"2026070109541865900_jfag037-B4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.2014.9132","article-title":"Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States","volume":"312","author":"Kwan","year":"2014","journal-title":"JAMA"},{"key":"2026070109541865900_jfag037-B5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaci.2012.04.004","article-title":"Delayed-onset adenosine deaminase deficiency: strategies for an early diagnosis","volume":"130","author":"Speckmann","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"2026070109541865900_jfag037-B6","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2018.08.024","article-title":"Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency","volume":"143","author":"Kohn","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2026070109541865900_jfag037-B7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fimmu.2016.00314","article-title":"Adenosine deaminase deficiency\u2014more than just an immunodeficiency","volume":"7","author":"Whitmore","year":"2016","journal-title":"Front Immunol"},{"key":"2026070109541865900_jfag037-B8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/eji.200425738","article-title":"New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency","volume":"35","author":"Hershfield","year":"2005","journal-title":"Eur J Immunol"},{"key":"2026070109541865900_jfag037-B9","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.3390\/s19122728","article-title":"Development of a simple assay method for adenosine deaminase via enzymatic formation of an inosine-Tb3+ complex","volume":"19","author":"Lee","year":"2019","journal-title":"Sensors (Basel)"},{"key":"2026070109541865900_jfag037-B10","doi-asserted-by":"crossref","first-page":"9181","DOI":"10.3390\/ijms22179181","article-title":"Enzyme therapy: current challenges and future perspectives","volume":"22","author":"de la Fuente","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026070109541865900_jfag037-B11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clinms.2020.07.002","article-title":"Development of dried blood spot quality control materials for adenosine deaminase severe combined immunodeficiency and LC-MS\/MS method for their characterization","volume":"17","author":"Young","year":"2020","journal-title":"Clin Mass Spectrom"},{"key":"2026070109541865900_jfag037-B12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/15257771003741406","article-title":"Determination of adenosine deaminase activity in dried blood spots by a nonradiochemical assay using reversed-phase high-performance liquid chromatography","volume":"29","author":"van Kuilenburg","year":"2010","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2026070109541865900_jfag037-B13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal Biochem"},{"key":"2026070109541865900_jfag037-B14","volume-title":"Evaluation of detection capability for clinical laboratory measurement procedures; approved guideline\u2014second edition. CLSI document EP17-A2","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2012"},{"key":"2026070109541865900_jfag037-B15","author":"US Food and Drug Administration"},{"key":"2026070109541865900_jfag037-B16","volume-title":"Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline\u2014third edition. CLSI document EP28-A3c","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2010"},{"key":"2026070109541865900_jfag037-B17","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaip.2023.01.032","article-title":"Updated management guidelines for adenosine deaminase deficiency","volume":"11","author":"Grunebaum","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026070109541865900_jfag037-B18","doi-asserted-by":"crossref","first-page":"114292","DOI":"10.1016\/j.ab.2021.114292","article-title":"Enzyme activity in dried blood spot as a diagnostic tool for adenosine deaminase 2 deficiency","volume":"628","author":"Ito","year":"2021","journal-title":"Anal Biochem"},{"key":"2026070109541865900_jfag037-B19","doi-asserted-by":"crossref","first-page":"1631S","DOI":"10.1093\/jn\/131.5.1631S","article-title":"Use of filter paper for the collection and analysis of human whole blood specimens","volume":"131","author":"Mei","year":"2001","journal-title":"J Nutr"},{"key":"2026070109541865900_jfag037-B20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/ac303205m","article-title":"Dried blood spots: analysis and applications","volume":"85","author":"Demirev","year":"2013","journal-title":"Anal Chem"},{"key":"2026070109541865900_jfag037-B21","doi-asserted-by":"crossref","first-page":"e22823","DOI":"10.1002\/jcla.22823","article-title":"Analytical validation of an in-house method for adenosine deaminase determination","volume":"33","author":"Silva Dalsasso Joaquim","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"2026070109541865900_jfag037-B22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0022-1759(84)90406-X","article-title":"A colorimetric assay for serial determination of adenosine deaminase activity in small lymphocyte populations","volume":"73","author":"Vielh","year":"1984","journal-title":"J Immunol Methods"},{"key":"2026070109541865900_jfag037-B23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0090-1229(76)90022-2","article-title":"A sensitive radiochemical assay for adenosine deaminase","volume":"5","author":"Mudawwar","year":"1976","journal-title":"Clin Immunol Immunopathol"},{"key":"2026070109541865900_jfag037-B24","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.3390\/molecules26185707","article-title":"A novel LC\u2013MS\/MS-based method for the diagnosis of ADA2 deficiency from dried plasma spot","volume":"26","author":"Cafaro","year":"2021","journal-title":"Molecules"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/11\/4\/758\/68119968\/jfag037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/11\/4\/758\/68119968\/jfag037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:29:21Z","timestamp":1782923361000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/11\/4\/758\/8659712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,21]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfag037","relation":{},"ISSN":["2475-7241"],"issn-type":[{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,4,21]]}}}